{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:43:36Z","timestamp":1779252216451,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"United States National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)","doi-asserted-by":"publisher","award":["AI082639"],"award-info":[{"award-number":["AI082639"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bcp.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T15:44:31Z","timestamp":1469202271000},"page":"162-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing"],"prefix":"10.1016","volume":"116","author":[{"given":"Tian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minlu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa C.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.07.009_b0005","series-title":"UNAIDS Report on the Global AIDS Epidemic","author":"UNAIDS","year":"2013"},{"issue":"5996","key":"10.1016\/j.bcp.2016.07.009_b0010","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.07.009_b0015","series-title":"MTN Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women","year":"2011"},{"issue":"27","key":"10.1016\/j.bcp.2016.07.009_b0020","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2016.07.009_b0040","unstructured":"J.M. Marrazzo, G. Ramjee, G. Nair, T. Palanee, B. Mkhize, C. Nakabiito, M. Taljaard, J. Piper, K. Gomez, M. Chirenje, Pre-exposure prophylaxis forHIV in women: daily oral tenofovir, oral tenofovir\/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003), CROI 2013 abstract #26LB."},{"issue":"4","key":"10.1016\/j.bcp.2016.07.009_b0045","first-page":"451","article-title":"Formulation, pharmacokinetics and pharmacodynamics of topical microbicides, best practice & research","volume":"26","author":"Adams","year":"2012","journal-title":"Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.bcp.2016.07.009_b0050","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2013.0122","article-title":"Pharmacokinetics and pharmacodynamics in HIV prevention: current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)\/pharmacodynamics (PD) in HIV prevention","author":"Romano","year":"2013","journal-title":"AIDS Res. Human Retroviruses"},{"issue":"6","key":"10.1016\/j.bcp.2016.07.009_b0055","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jcph.292","article-title":"Topical microbicides and HIV prevention in the female genital tract","volume":"54","author":"Cottrell","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2016.07.009_b0060","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.antiviral.2010.09.011","article-title":"Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities","volume":"88","author":"Hladik","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bcp.2016.07.009_b0065","article-title":"Rectal microbicide development","author":"McGowan","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"9787","key":"10.1016\/j.bcp.2016.07.009_b0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(11)60878-7","article-title":"Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women","volume":"378","author":"Karim","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bcp.2016.07.009_b0075","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1089\/aid.2012.0073","article-title":"Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study","volume":"28","author":"Richardson-Harman","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"3","key":"10.1016\/j.bcp.2016.07.009_b0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clpt.2005.05.011","article-title":"Transporters and drug therapy: implications for drug disposition and disease","volume":"78","author":"Ho","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2016.07.009_b0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"10.1016\/j.bcp.2016.07.009_b0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/135965350901400514","article-title":"Maraviroc: pharmacokinetics and drug interactions","volume":"14","author":"Abel","year":"2009","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2016.07.009_b0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":"Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2016.07.009_b0105","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2016.07.009_b0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2010.04.019","article-title":"The effects of excipients on transporter mediated absorption","volume":"393","author":"Goole","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bcp.2016.07.009_b0115","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.pharmthera.2011.06.007","article-title":"Drug uptake transporters in antiretroviral therapy","volume":"132","author":"Minuesa","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2016.07.009_b0120","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1089\/aid.2013.0281","article-title":"Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque","volume":"30","author":"Zhou","year":"2014","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"12","key":"10.1016\/j.bcp.2016.07.009_b0125","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/mp5005004","article-title":"Vaginal expression of efflux transporters and the potential impact on the disposition of microbicides in vitro and in rabbits","volume":"11","author":"Grammen","year":"2014","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.bcp.2016.07.009_b0130","doi-asserted-by":"crossref","first-page":"e0131405","DOI":"10.1371\/journal.pone.0131405","article-title":"Expression of genes for drug transporters in the human female genital tract and modulatory effect of antiretroviral drugs","volume":"10","author":"Hijazi","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0135","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcph.248","article-title":"Expression of six drug transporters in vaginal, cervical, and colorectal tissues: implications for drug disposition in HIV prevention","volume":"54","author":"Nicol","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2016.07.009_b0140","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1089\/aid.2013.0032","article-title":"Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research","volume":"29","author":"Zhou","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.bcp.2016.07.009_b0145","article-title":"Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization","author":"Mukhopadhya","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.07.009_b0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jconrel.2015.08.018","article-title":"Drug transporters in tissues and cells relevant to sexual transmission of HIV: implications for drug delivery","volume":"219","author":"Hu","year":"2015","journal-title":"J. Controlled Release"},{"issue":"2","key":"10.1016\/j.bcp.2016.07.009_b0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/pr.55.2.1","article-title":"Gender differences in the membrane transport of endogenous and exogenous compounds","volume":"55","author":"Morris","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2016.07.009_b0160","series-title":"Current Protocols in Neuroscience\/Editorial Board","article-title":"Assessing reproductive status\/stages in mice","author":"Caligioni","year":"2009"},{"key":"10.1016\/j.bcp.2016.07.009_b0165","series-title":"Injectable Contraception and HIV Risk in VOICE. Secondary Analysis Results QA","author":"MTN","year":"2014"},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0170","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1128\/AAC.48.5.1837-1847.2004","article-title":"Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides","volume":"48","author":"Catalone","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2016.07.009_b0175","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1128\/AAC.49.4.1509-1520.2005","article-title":"Comparative safety evaluation of the candidate vaginal microbicide C31G","volume":"49","author":"Catalone","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.bcp.2016.07.009_b0180","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2016.07.009_b0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1054\/plef.2000.0167","article-title":"Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571","volume":"62","author":"Blain","year":"2000","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"43","key":"10.1016\/j.bcp.2016.07.009_b0190","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1073\/pnas.0808993105","article-title":"Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors","volume":"105","author":"Maekawa","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2016.07.009_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009310","article-title":"In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide","volume":"5","author":"Rohan","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2016.07.009_b0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1208\/s12248-009-9082-7","article-title":"Vaginal drug delivery systems for HIV prevention","volume":"11","author":"Rohan","year":"2009","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.bcp.2016.07.009_b0205","first-page":"295","article-title":"Animal models for microbicide safety and efficacy testing","volume":"8","author":"Veazey","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2016.07.009_b0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.bcp.2016.07.009_b0215","series-title":"Residues of Some Veterinary Drugs in Animals and Foods: Monographs Prepared by the Sixty-Second Meeting of the Joint FAO\/WHO Expert Committee on Food Additives, Rome, 4-12 February 2004","article-title":"Meeting (62nd: 2004: Rome Italy), Food and Agriculture Organization of the United Nations, World Health Organization","author":"Joint FAO\/WHO Expert Committee on Food Additives","year":"2004"},{"key":"10.1016\/j.bcp.2016.07.009_b0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fonc.2012.00178","article-title":"ABCC4\/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma","volume":"2","author":"Huynh","year":"2012","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2016.07.009_b0225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2016.07.009_b0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.pcan.4500912","article-title":"Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells","volume":"10","author":"Cai","year":"2007","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"13","key":"10.1016\/j.bcp.2016.07.009_b0235","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/pros.20809","article-title":"Androgen regulation of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in prostate cancer","volume":"68","author":"Ho","year":"2008","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0240","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/clpt.2010.189","article-title":"Pharmacologic opportunities for HIV prevention","volume":"88","author":"Nicol","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2016.07.009_b0245","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1097\/QAI.0b013e3182986ff8","article-title":"Antiretroviral pharmacology in mucosal tissues","volume":"63","author":"Thompson","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"10","key":"10.1016\/j.bcp.2016.07.009_b0250","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/infdis\/jir059","article-title":"Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men","volume":"203","author":"Brown","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2016.07.009_b0255","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QAI.0b013e3181ae69c5","article-title":"Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women","volume":"51","author":"Dumond","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"14","key":"10.1016\/j.bcp.2016.07.009_b0260","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/QAD.0b013e328270385a","article-title":"Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis","volume":"21","author":"Dumond","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.bcp.2016.07.009_b0265","first-page":"255","article-title":"Nonhuman primate models in AIDS research","volume":"8","author":"Evans","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"4","key":"10.1016\/j.bcp.2016.07.009_b0270","first-page":"280","article-title":"Using nonhuman primates to model HIV transmission","volume":"8","author":"Fennessey","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"112","key":"10.1016\/j.bcp.2016.07.009_b0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2016.07.009_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055013","article-title":"MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments","volume":"8","author":"Hendrix","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2016.07.009_b0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1095\/biolreprod.110.090423","article-title":"Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia","volume":"85","author":"Blaskewicz","year":"2011","journal-title":"Biol. Reprod."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216301745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T17:46:24Z","timestamp":1656870384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216301745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":57,"alternative-id":["S0006295216301745"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.07.009","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}